I don't think that can impact much on the outlook until such time as the company shows the knack of turning sales revenue into profit. Likewise I think the share price is probably going nowhere until that is shown too. And I really cannot see that tiny profits are going to change that outlook either. Something more noticeable is needed to my mind.
There are two new board members now. Will that impact on results this financial year? I hope so as the results are not electric presently.
Blis products do not target the gut, so this research is not relevant. The relevant research actually looking at blis products is much more supportive
Agreed that the oral cavity is a totally different ecological niche and there are different dynamics at play BUT.....as always, the problem is that BLIS need sales. Enough sales that they can't rely on only selling to the over-informed. As a very easy popular press headline this study is unhelpful (or neutral at best).
That story was even on the main TV news last night ....unless the uninformed really paid attention the message was probiotics not much use (for anything)
Bookmarks